Stocktoria

PROCEPT BioRobotics Corp PRCT

Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-09-15
Chart by TradingView
3/9
Piotroski F — financial health
2.18
Altman Z″ — distress risk · grey
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Revenue$308.1M$224.5M$136.2M$75.0M$34.5M
Gross profit$196.2M$137.1M$71.0M$37.1M$15.9M
Operating income-$103.9M-$96.6M-$109.2M-$80.7M-$54.2M
Net income-$95.6M-$91.4M-$105.9M-$87.2M-$59.9M
Operating cash flow-$49.0M-$99.2M-$108.0M-$80.4M-$57.3M
Free cash flow-$58.3M-$103.6M-$133.2M-$83.0M-$57.9M
Total assets$508.1M$534.0M$404.7M$309.3M$337.0M
Total liabilities$142.2M$131.8M$124.0M$112.3M$69.9M
Shareholders' equity$365.9M$402.2M$280.8M$197.1M$267.1M
Ratios
Gross margin63.7%61.1%52.2%49.4%46.0%
Operating margin-33.7%-43.0%-80.2%-107.6%-157.1%
Net margin-31.0%-40.7%-77.8%-116.2%-173.6%
FCF margin-18.9%-46.2%-97.8%-110.7%-168.0%
Return on assets-18.8%-17.1%-26.2%-28.2%-17.8%
Return on equity-26.1%-22.7%-37.7%-44.2%-22.4%
Debt / equity0.14×0.13×0.18×0.26×0.19×
Current ratio6.859.077.637.7320.08
Revenue growth37.2%64.8%81.6%117.6%346.7%

Notable holders (13F)

InvestorSharesValue
Point72 Asset Management, L.P.1,139,943$28.5M
RENAISSANCE TECHNOLOGIES LLC116,166$2.9M

Why these scores methodology →

Piotroski F-score: 3/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: 2.18 (grey)

  • Working capital / assets 0.757
  • Retained earnings / assets -1.263
  • EBIT / assets -0.204
  • Equity / liabilities 2.573

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001588978 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.